All Articles

Millions of Californians live under HOA rule. A new guide by a top attorney offers battle-tested strategies to fight mismanagement and protect property values.

Mercanto Holdings enters Québec's untapped vape market with a calculated product and hardware strategy, aiming for a key share of a lucrative new category.

As DFW companies battle employee fatigue, a new trend emerges: on-site IV therapy. But is it a medical innovation or a high-priced wellness fad?

An Israeli firm's MEMS-based device is expanding to 30+ countries, promising painless injections and a new era for aesthetics, vaccines, and medicine.

Ohio's Bloom dispensaries are collecting toys and food, but this is more than holiday spirit. It's a strategic move in the industry's quest for legitimacy.

For the second straight year, Speedway Motorsports is a 'Best Place to Work.' We look at the strategy behind the trophy and how a happy team fuels fan experience.

EA's new ENVISION platform embeds AI and privacy-by-design, aiming to outmaneuver rivals and offer Canadian marketers a decisive strategic advantage.

With a prestigious award nomination, SKONEC's 'Who's at the Door?' uses psychological horror and a multi-platform launch to knock on the global stage.

How a grooming brand's UAE launch reveals the hidden infrastructure of modern commerce, turning digital demand into physical presence at mobility hubs.

With SurveyMonkey's CEO and Cloudflare's CMO on its board, Vendasta is accelerating its mission to equip small businesses with an autonomous AI workforce.

As AdaptHealth preps for a key investor conference, we explore how tech-infused home healthcare is becoming the next frontier for savvy investors.

Moleculin Biotech's 1-for-25 reverse split aims to save its Nasdaq spot, but a history of dilution casts a shadow over its promising cancer drug pipeline.

A biotech's AI can now rationally design high-affinity antibodies from just 50 sequences, promising to slash drug development costs and timelines.

SailGP isn't just a race; it's a revolution. Discover how its Impact League is making sustainability a competitive sport and setting a new industry blueprint.

With a fortified balance sheet and promising cancer data, Galmed is strategically diversifying its lead drug, Aramchol, beyond its liver disease origins.

As wildfires rage, Cyprus’s tech sector, government, and private industry unite at HackTech 2025 to forge innovative digital defenses against a burning threat.

With a new European patent, Finnish telecom Elisa offers a proven fix for the €850M scam call problem, setting a new standard for continental security.

As Moleculin Biotech preps for a key investor address, its promising cancer drug Annamycin faces a critical race against mounting financial pressures.

As Exzeo Group preps its Q3 earnings call, we explore how its 'Insurance-as-a-Service' model is reshaping the high-stakes P&C insurance market.

A new startup, TISC, has emerged with $2.1M in funding to replace guesswork with 'AI intuition' in sports, defense, and emergency response.